Nasdaq Cers News Today

Cerus (NASDAQ:CERS – Free Report) had its price objective raised by Cantor Fitzgerald from $3.00 to $4.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. A number of other analysts have also commented on CERS. Stephens reiterated an equal weight […]

Cerus (NASDAQ:CERS – Get Free Report) and Co-Diagnostics (NASDAQ:CODX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Risk and Volatility Cerus has a beta of 1.31, […]

Cerus Co. (NASDAQ:CERS – Get Free Report) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 4,480,000 shares, a growth of 5.9% from the January 15th total of 4,230,000 shares. Based on an average trading volume of 1,420,000 shares, the short-interest ratio is presently 3.2 days. […]

Cerus Co. (NASDAQ:CERS – Get Free Report) Director Eric Bjerkholt acquired 10,000 shares of Cerus stock in a transaction dated Wednesday, December 13th. The stock was acquired at an average cost of $1.62 per share, with a total value of $16,200.00. Following the completion of the transaction, the director now directly owns 142,133 shares of […]

Cerus (NASDAQ:CERS – Get Free Report) and Tenon Medical (NASDAQ:TNON – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability. Volatility and Risk Cerus has a beta of […]

Hood River Capital Management LLC lessened its stake in shares of Cerus Co. (NASDAQ:CERS – Free Report) by 6.2% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,866,849 shares of the biotechnology company’s stock after selling 254,002 shares during the quarter. Hood River […]

Cerus Co. (NASDAQ:CERS – Get Free Report) Director Ann Lucena purchased 7,500 shares of the business’s stock in a transaction on Tuesday, August 22nd. The stock was bought at an average cost of $1.69 per share, for a total transaction of $12,675.00. Following the purchase, the director now owns 72,284 shares of the company’s stock, […]

Cerus Co. (NASDAQ:CERS – Get Free Report) shares rose 9.4% during trading on Tuesday . The company traded as high as $2.80 and last traded at $2.78. Approximately 779,121 shares traded hands during trading, a decline of 46% from the average daily volume of 1,442,407 shares. The stock had previously closed at $2.54. Wall Street […]

StockNews.com initiated coverage on shares of Cerus (NASDAQ:CERS – Get Rating) in a report published on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research cut shares of Cerus from a buy rating to a neutral rating in a report on Friday, January 20th. Cerus Trading Up 5.0 % […]

StockNews.com assumed coverage on shares of Cerus (NASDAQ:CERS – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, BTIG Research lowered Cerus from a “buy” rating to a “neutral” rating in a report on Friday, January 20th. Cerus Stock […]